Search results
From WikiMD's Food, Medicine & Wellness Encyclopedia
Create the page "(S)-(1-carboxy-2-phenylethyl)carbamoyl-L-arginine" on this wiki! See also the search results found.
- ...to the relatively nontoxic excretion product urea at the cost of four "high-energy" phosphate bonds (3 ATP hydrolyzed to 2 ADP and one AMP). ...on of ammonia and bicarbonate to form carbamoyl phosphate. This is the rate-limiting step of the urea cycle. The reaction requires two molecules of ATP,3 KB (442 words) - 18:18, 25 February 2024
- ...atment is based on the symptoms. Seizures can be treated with specific anti-seizure medications. In severe cases, [[liver transplant]] may be an option. The medication(s) listed below have been approved by the Food and Drug Administration (FDA)6 KB (912 words) - 14:29, 27 April 2021
- | name = N-Acetylglutamate synthase deficiency | image = N-AcetylglutamicAcid.png5 KB (581 words) - 01:02, 23 February 2024
- ...3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)-(phenoxy)phosphorylamino)propanoate'' ...]imidazol-9-yl}-1H-imidazol-2-yl)-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl}carbamate''6 KB (842 words) - 18:27, 24 July 2021
- One cofactor-producing enzyme: * N-acetyl glutamate synthetase (NAGS)7 KB (1,044 words) - 10:21, 23 July 2020
- * '''[[17-alpha-hydroxylase deficiency]]''' * '''[[17-beta hydroxysteroid dehydrogenase 3 deficiency]]'''22 KB (2,804 words) - 22:50, 18 September 2019
- ...f acute [[hyperammonemia]] due to [[N-acetylglutamate synthase deficiency|N-acetylglutamate synthase]] (NAGS) deficiency. ...metabolite that activates the enzyme carbamoyl phosphate synthetase I (CPS-1), the first step in the [[urea cycle]] which is responsible for removal an8 KB (1,108 words) - 13:32, 22 December 2022
- ...{{cite web|url=https://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency|title=Ornithing transcarbamylase deficiency |date=22 May 2018 |ac ...nd [[ornithine]] into [[citrulline]]. OTC deficiency is inherited in an [[X-linked recessive]] manner, meaning males are more commonly affected than fem15 KB (1,976 words) - 17:13, 22 February 2024
- ...disorders''' encompass a broad range of conditions resulting from the body's inability to process certain nutrients and chemicals due to enzyme deficien ...sorders''': Conditions arising from defects in the mitochondria, the energy-producing parts of cells. Examples are:26 KB (3,173 words) - 19:37, 20 September 2023
- ...iency, carnitine palmitoyl transferase 1 deficiency, long chain hydroxyacyl-CoA dehydrogenase deficiency ...ell as it should. Most often these altered genes are inherited from parent(s), but they may also occur spontaneously.6 KB (887 words) - 15:43, 8 July 2020
- This is a list of [[disease]]s starting with the letter "O". * [[Ocular coloboma-imperforate anus]]10 KB (900 words) - 04:30, 4 October 2019
- ...d from one or both parents or can occur spontaneously during an individual's life. The genes carry instructions that guide the growth, development, and ...les include [[sickle cell disease]], [[cystic fibrosis]], and [[Huntington's disease]].22 KB (2,005 words) - 02:46, 12 September 2023
- This is a list of [[disease]]s starting with the letter "C". * [[Caffeine-induced sleep disorder]]40 KB (3,786 words) - 04:19, 20 April 2020
- ...'' see '''[https://ghr.nlm.nih.gov/condition/bohring-opitz-syndrome Bohring-Opitz syndrome]''' ...ibitor deficiency]]''' see '''[https://ghr.nlm.nih.gov/condition/hereditary-angioedema Hereditary angioedema]'''114 KB (14,485 words) - 20:56, 18 March 2024
- ...disease usually is an estimate and may change over time. Inclusion in GARD's list does not serve as official recognition by the NIH as a rare disease an ...A-approved treatments, and many drugs used to treat these diseases are "off-label" or used without FDA approval. This can make it difficult for patients27 KB (3,296 words) - 03:40, 12 January 2023
- * '''[https://ghr.nlm.nih.gov/gene/AASS AASS]''': aminoadipate-semialdehyde synthase * '''[https://ghr.nlm.nih.gov/gene/ABAT ABAT]''': 4-aminobutyrate aminotransferase121 KB (20,808 words) - 02:03, 14 March 2024
- * [[2-acetamidoethanol]] * [[N-acetyl-n-(2-hydroxyethyl)-n'-oleoylethylenediamine]]134 KB (11,253 words) - 21:51, 24 December 2022
- * '''[[C-Peptide]]''' * '''[[C-Reactive Protein]]'''97 KB (12,845 words) - 03:43, 10 March 2024
- * '''[[A-17 Propellant]]''' ...ium salt (1:1), reaction products with 4,5-dihydro-2-undecyl-1H-imidazole-1-ethanol and sodium hydrox]]'''175 KB (22,888 words) - 17:43, 19 March 2024
- ...majority of solid tumors. Upon internalization and proteolytic cleavage, SN-38, the active metabolite of irinotecan, inhibits the activity of topoisomer ...f the KIR family, is specifically expressed in most subtypes of cutaneous T-cell lymphomas (CTCL) and expressed only on a fraction of normal NK cells.127 KB (17,614 words) - 01:34, 19 March 2024